Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Favorable pharmacokinetic and pharmacodynamic properties of gilteritinib in cerebrospinal fluid: a potential effective treatment in relapsing meningeal acute myeloid leukemia FLT3-ITD patients.
Vignal N, Kelly L, Lengline E, Cabannes-Hamy A, Siavellis J, Ghez D, Sauvageon H, Braun T, Jacqz-Aigrain E, Kohn M, Rousselot P, Puissant A, Raffoux E, Mourah S, Goldwirt L. Vignal N, et al. Among authors: mourah s. Haematologica. 2023 Sep 1;108(9):2531-2534. doi: 10.3324/haematol.2022.282596. Haematologica. 2023. PMID: 36794507 Free PMC article. No abstract available.
Severe relapses of cutaneous T-cell lymphoma after treatment of chronic graft-versus-host disease with ruxolitinib.
Cohen E, Bozonnat A, Battistella M, Calvani J, Vignon-Pennamen MD, Rivet J, Moins-Teisserenc H, Ta VA, Ram-Wolff C, Bouaziz JD, Mahevas T, Bagot M, Mourah S, Louveau B, Sicre de Fontbrune F, Peffault de Latour R, de Masson A, Battesti G. Cohen E, et al. Among authors: mourah s. J Eur Acad Dermatol Venereol. 2024 Jan;38(1):e32-e34. doi: 10.1111/jdv.19408. Epub 2023 Aug 23. J Eur Acad Dermatol Venereol. 2024. PMID: 37561935 No abstract available.
Graft-versus-lymphoma effect in skin after allogeneic hematopoietic stem cell transplantation for Sézary syndrome.
Ranjbaryan M, Calvani J, Louveau B, Cuccuini W, Battesti G, Bozonnat A, Moins-Teisserenc H, Michonneau D, Bagot M, Ram-Wolff C, Dobos G, Mourah S, Battistella M, de Masson A. Ranjbaryan M, et al. Among authors: mourah s. Eur J Dermatol. 2023 Aug 1;33(4):439-440. doi: 10.1684/ejd.2023.4522. Eur J Dermatol. 2023. PMID: 37823502 No abstract available.
Toxic epidermal necrolysis possibly associated with mogamulizumab in a patient with Sézary syndrome.
Lazaridou I, Calvani J, Annabi E, Moins-Teisserenc H, Ta VA, Rivet J, Ram-Wolff C, Dumont M, Mahevas T, Vignon-Pennamen MD, Mourah S, Bouaziz JD, Louveau B, Bagot M, Battistella M, de Masson A. Lazaridou I, et al. Among authors: mourah s. J Eur Acad Dermatol Venereol. 2023 Jun;37(6):e715-e717. doi: 10.1111/jdv.18868. Epub 2023 Jan 21. J Eur Acad Dermatol Venereol. 2023. PMID: 36645855 No abstract available.
Detection of BRAF V600 mutations in melanoma: evaluation of concordance between the Cobas® 4800 BRAF V600 mutation test and the methods used in French National Cancer Institute (INCa) platforms in a real-life setting.
Mourah S, Denis MG, Narducci FE, Solassol J, Merlin JL, Sabourin JC, Scoazec JY, Ouafik L, Emile JF, Heller R, Souvignet C, Bergougnoux L, Merlio JP. Mourah S, et al. PLoS One. 2015 Mar 19;10(3):e0120232. doi: 10.1371/journal.pone.0120232. eCollection 2015. PLoS One. 2015. PMID: 25789737 Free PMC article.
159 results